Multidisciplinary board for interstitial lung disease: Relevance for real life?

Sabina Guler (Bern, Switzerland), Sabina Guler, Sabina Anna Berezowska, Andreas Christe, Geiser Thomas, Funke Manuela

Source: International Congress 2015 – New insights into IIPs
Session: New insights into IIPs
Session type: Poster Discussion
Number: 4857
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sabina Guler (Bern, Switzerland), Sabina Guler, Sabina Anna Berezowska, Andreas Christe, Geiser Thomas, Funke Manuela. Multidisciplinary board for interstitial lung disease: Relevance for real life?. Eur Respir J 2015; 46: Suppl. 59, 4857

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Interstitial lung disease: the Japanese perspective
Source: International Congress 2017 – Ethnic differences and their clinical impact on respiratory diseases in Europe and Japan
Year: 2017


Teleradiology in interstitial lung disease: first experiences
Source: International Congress 2017 – Rare diseases
Year: 2017


Interstitial lung disease: ?course report
Source: Breathe, 16 (3) 200075; 10.1183/20734735.0075-2020
Year: 2020



Quality of life in interstitial lung disease: Utility of the Kings brief interstitial lung disease questionairre at baseline
Source: International Congress 2015 – New insights into IIPs
Year: 2015

Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021

Access for REGISTERED non-members

Year: 2021

Relevance of the expert ILD clinical-radiological evaluation of referred cases to the MDT
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease?
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015


Survival rates after a rehabilitation program in patients with interstitial lung disease
Source: International Congress 2014 – Physiotherapy and physical activity in respiratory conditions
Year: 2014

Interstitial lung diseases: a clinical update
Source: Eur Respir J 2001; 18: 1S
Year: 2001


A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016

Development of the interstitial lung disease multidiciplinary team meeting 2005-2013
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Childhood interstitial lung disease: A diagnostic challenge
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

The value of a specialist nurse-lead interstitial lung disease clinic, patients’ views
Source: International Congress 2015 – Kaleidoscope of nursing research
Year: 2015


Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Interstitial lung disease
Source: Eur Respir Rev 2014; 23: 40-54
Year: 2014



Interstitial lung disease
Source: Eur Respir Monogr 2019; 83: 173-187
Year: 2019


Interstitial lung disease
Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Year: 2019


Interstitial lung disease
Source: ERS Course 2015
Year: 2015